The field of vaccinology underwent massive advances over the past decades with the
introduction of virus-like particles (VLPs), a supra-molecular nanoparticle vaccine platform …

There is an unmet need to unearth alternative treatment options for malaria, wherein this
quest is more pressing in recent times due to high morbidity and mortality data arising mostly …

Pathogens require physical contact with the mucosal surface of the host organism to initiate
infection and as such, vaccines eliciting both mucosal and systemic immune responses …

Recombinant vaccinia viruses (rVV) are effective antigen delivery vectors and are
researched widely as vaccine platforms against numerous diseases. Apical membrane …

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has wreaked havoc around the globe, with no end in sight. The rapid …

Heterologous prime–boost immunization regimens using various vaccine platforms
demonstrated promising results against infectious diseases. Here, mice were sequentially …

Virus-like particles (VLP) are a highly efficient vaccine platform used to present multiple
antigenic proteins. Merozoite surface protein 8 (MSP-8), 9 (MSP-9) and rhoptry-associated …

Background Apical membrane antigen 1 (AMA1) and microneme-associated antigen (MIC)
of Plasmodium parasites are important factors involved in host cell invasion. Methods In this …

Malaria is a global disease affecting a large portion of the world's population. Although
vaccines have recently become available, their efficacies are suboptimal. We generated …